Ipratropium and albuterol solution is approved for treating and preventing airway spasms due to COPD. This eMedTV resource discusses general precautions with the drug, explains how it works, and describes tips for when and how to use the medication.
This eMedTV page explains that side effects of ipratropium and albuterol solution can include nausea, diarrhea, and bronchitis. This page lists other common side effects of the drug and describes serious side effects that may require medical care.
Ipratropium and albuterol solution is approved for the treatment of breathing problems due to COPD. This eMedTV segment takes an in-depth look at ipratropium and albuterol solution uses, including its "off-label" use to treat asthma.
As this eMedTV page explains, the recommended standard dose of ipratropium and albuterol solution for treating COPD is one 3-mL vial inhaled four times a day. This page also provides ipratropium and albuterol solution dosing guidelines.
This eMedTV page explains that drug interactions with ipratropium and albuterol solution can occur when it is taken with drugs such as digoxin and MAOIs. This page lists other drugs that can cause interactions and covers the problems that may occur.
Ipratropium and albuterol solution can worsen glaucoma, bladder problems, and breathing problems. This eMedTV segment offers other important precautions and warnings with ipratropium and albuterol solution, including who should not take the drug.
